Source:http://linkedlifedata.com/resource/pubmed/id/10590284
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2000-2-29
|
pubmed:abstractText |
Tentative MIC and zone diameter breakpoints were determined for moxifloxacin using BSAC criteria. An MIC breakpoint of < or =1 mg/L, denoting sensitivity, is suggested for Enterobacteriaceae, staphylococci, haemophili, moraxellae, pneumococci and enterococci. For pseudomonads high and low breakpoints of 4 mg/L and 1 mg/L are suggested to allow for an intermediate category of sensitivity. A 1 microg moxifloxacin disc content is suggested for testing all of the organisms previously mentioned, except pseudomonads, for which a 5 microg disc is needed to discriminate between the intermediate and sensitive populations. Corresponding zone diameter breakpoints for a 1 microg disc are > or = 20 mm for Enterobacteriaceae and staphylococci, 18 mm for the respiratory pathogens (Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis) and 15 mm for enterococci. For Pseudomonas aeruginosa with a 5 microg disc, three bands are suggested for interpretation, that of > or = 25 mm (sensitive), 18-24 mm (intermediate) and < or = 17 mm (resistant).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Infective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Aza Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Fluoroquinolones,
http://linkedlifedata.com/resource/pubmed/chemical/Quinolines,
http://linkedlifedata.com/resource/pubmed/chemical/moxifloxacin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0305-7453
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
819-22
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10590284-Anti-Infective Agents,
pubmed-meshheading:10590284-Aza Compounds,
pubmed-meshheading:10590284-Fluoroquinolones,
pubmed-meshheading:10590284-Gram-Negative Bacteria,
pubmed-meshheading:10590284-Gram-Positive Bacteria,
pubmed-meshheading:10590284-Humans,
pubmed-meshheading:10590284-Microbial Sensitivity Tests,
pubmed-meshheading:10590284-Quinolines
|
pubmed:year |
1999
|
pubmed:articleTitle |
Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteria.
|
pubmed:affiliation |
Department of Antimicrobial Chemotherapy, City Hospital NHS Trust, Dudley Road, Birmingham B18 7QH, UK.
|
pubmed:publicationType |
Journal Article
|